Viewing StudyNCT00417170



Ignite Creation Date: 2024-05-05 @ 5:15 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00417170
Status: COMPLETED
Last Update Posted: 2011-09-26
First Post: 2006-12-28

Brief Title: Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Endothelial Dysfunction
High Blood Pressure
Metabolic Syndrome
Insulin Resistance
Keywords:
Name View
MBF View
High Blood pressure View
Hypertension View
metabolic syndrome View
insulin resistance View
endothelial dysfunction View
pre-diabetic View
amlodipine View
aliskiren View
IGT View
IFG View